In vitro susceptibility of Capnocytophaga species to antimicrobial agents.
A total of 33 clinical isolates of Capnocytophaga spp. were susceptible to 4-quinolone antimicrobial agents. The antipseudomonal penicillins tested were equally active against all isolates, as were cefuroxime, ceftriaxone, ceftizoxime, cefotaxime, latamoxef, and ceftazidime. Most isolates were resistant to trimethoprim, and some were resistant to aztreonam. Most regimens for the empirical treatment of septic episodes in immunocompromised patients are suitable for the treatment of Capnocytophaga spp. infections.
9 references, click to expand
-
Capnocytophaga: new genus of gram-negative gliding bacteria. III. Physiological characterization.Arch Microbiol. 1979 Jul;122(1):29-33 PMID: 518236
-
Capnocytophaga sepsis: a newly recognised clinical entity in granulocytopenic patients.Lancet. 1980 Mar 15;1(8168 Pt 1):567-8 PMID: 6102287
-
Antimicrobial susceptibility of Capnocytophaga.Antimicrob Agents Chemother. 1981 Jan;19(1):144-6 PMID: 7247353
-
In vitro susceptibility of Capnocytophaga strains to 18 antimicrobial agents.Antimicrob Agents Chemother. 1981 Aug;20(2):270-1 PMID: 7283424
-
Antibacterial activity of ofloxacin and other 4-quinolone derivatives: in-vitro and in-vivo comparison.J Antimicrob Chemother. 1985 Oct;16(4):475-84 PMID: 3864775
-
Capnocytophaga ochracea infection: two cases and a review of the published work.J Clin Pathol. 1984 Sep;37(9):1066-70 PMID: 6470184
-
Capnocytophaga species: infections in nonimmunocompromised and immunocompromised hosts.J Infect Dis. 1985 Jan;151(1):140-7 PMID: 3965585
-
Capnocytophaga ochracea: an unusual opportunistic pathogen.J Clin Pathol. 1985 Sep;38(9):1081-2 PMID: 4044877
-
In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.Antimicrob Agents Chemother. 1983 Apr;23(4):559-64 PMID: 6222695
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: [email protected]
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
